The Clorox Company $CLX Shares Bought by Mutual Advisors LLC

Mutual Advisors LLC grew its holdings in shares of The Clorox Company (NYSE:CLX) by 63.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,634 shares of the company’s stock after purchasing an additional 1,022 shares during the quarter. Mutual Advisors LLC’s holdings in Clorox were worth $345,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Wealth Enhancement Advisory Services LLC boosted its position in shares of Clorox by 17.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 57,934 shares of the company’s stock valued at $8,531,000 after acquiring an additional 8,793 shares during the last quarter. QRG Capital Management Inc. boosted its position in shares of Clorox by 10.0% during the 1st quarter. QRG Capital Management Inc. now owns 2,492 shares of the company’s stock valued at $367,000 after acquiring an additional 226 shares during the last quarter. State of Alaska Department of Revenue boosted its position in shares of Clorox by 2.2% during the 1st quarter. State of Alaska Department of Revenue now owns 14,430 shares of the company’s stock valued at $2,124,000 after acquiring an additional 315 shares during the last quarter. PFG Investments LLC boosted its position in shares of Clorox by 13.2% during the 1st quarter. PFG Investments LLC now owns 4,154 shares of the company’s stock valued at $612,000 after acquiring an additional 485 shares during the last quarter. Finally, Stonegate Investment Group LLC boosted its position in shares of Clorox by 52.7% during the 1st quarter. Stonegate Investment Group LLC now owns 2,070 shares of the company’s stock valued at $305,000 after acquiring an additional 714 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 0.1%

Shares of NYSE:CLX opened at $119.60 on Tuesday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market capitalization of $14.56 billion, a PE ratio of 18.34, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The firm’s 50-day moving average is $121.56 and its two-hundred day moving average is $127.42. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s dividend payout ratio is 76.07%.

Analyst Ratings Changes

Several brokerages have recently weighed in on CLX. Barclays lowered their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. Wells Fargo & Company reduced their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a report on Thursday, September 25th. The Goldman Sachs Group reduced their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a report on Wednesday, October 1st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $130.20.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.